Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®
Adds an additional commercial and strategic rare disease product to Eton’s portfolioGalzin is FDA-approved for the treatment ...
Medscape1 年
Fatty Liver: A Primary Care Approach
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...